CABESTRILLO S-CONFOR PED CH PZ MATERIAL DE CURACIONLABORATORIOS LEROY SA DE C advertir sobre efectos extrapiramidales o

Description

advertir sobre efectos extrapiramidales o sedación

PRINCIPIO ACTIVO: BUDESONIDA

PRINCIPIO ACTIVO: CLINDAMICINA FOSFATO 600 MG

IMBRUVICA 140 mg | Cápsulas | Caja con 120 | Janssen-Cilag

CABESTRILLO S-CONFOR PED CH PZ MATERIAL DE CURACIONLABORATORIOS LEROY SA DE C advertir sobre efectos extrapiramidales o

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy